BridgeBio Pharma, Inc. earnings per share and revenue

BBIO earnings per share for the last quarter are -1.40 USD whereas the estimation was -1.12 USD which accounts for -24.98% surprise. Company revenue for the same period amounts to 5.88 M USD despite the estimated figure of 3.07 M USD. Estimated earnings per share for the next quarter are -0.94 USD, and revenue is expected to reach 46.48 M USD. Also watch annual changes over time to get a bigger picture of BBIO earnings per share and revenue dynamics.